Companies
MSCI
MSCI (founded 1998) publishes the 44 trillion US dollar nature-risk framing and assesses biodiversity exposure across its investable indexes.
- Country
- United States
Commercial
Biodiversity / Nature Risk
Coverage
| CN | EU | US | |
|---|---|---|---|
| finance-investment | ✓ | ✓ | ✓ |
| standards-certification | ✓ | ✓ | ✓ |
Regulatorsepareachmoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | $3,134.46 million for the year ended December 31, 2025 | msci.gcs-web.com |
| Headcount | 6,268 employees as of December 31, 2025 | msci.gcs-web.com |
| Capacity | Coverage of approximately 4 million asset locations for over 780,000 public and private companies | ir.msci.com · msci.com · sec.gov |
| Regulatory approval | MSCI Limited is authorized by the UK Financial Conduct Authority (FCA) and MSCI Deutschland GmbH is authorized by Germany’s Federal Financial Supervisory Authority (BaFin) and the European Securities and Markets Authority (ESMA) as benchmark administrators. Other products are not submitted to or approved by the SEC or other regulatory bodies. | ir.msci.com · msci.com · sec.gov |
| Headquarters | 7 World Trade Center, 250 Greenwich Street, 49th Floor, New York, New York, 10007 | sec.gov |
Independent sources: sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-risk modeling for finance | finance-investment | Low | → |
| TNFD disclosures & nature-related accounting | standards-certification | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.